Balboa Wealth Partners Corcept Therapeutics Inc Transaction History
Balboa Wealth Partners
- $398 Million
- Q1 2025
A detailed history of Balboa Wealth Partners transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Balboa Wealth Partners holds 2,936 shares of CORT stock, worth $217,087. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,936
Previous 3,983
26.29%
Holding current value
$217,087
Previous $200,000
67.5%
% of portfolio
0.08%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
454Shares Held
84.1MCall Options Held
1.11MPut Options Held
1.82M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$738 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$572 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$454 Million1.13% of portfolio
-
Parallel Advisors, LLC3.97MShares$294 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.92B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...